Renée Galá
Präsident bei JAZZ PHARMACEUTICALS PLC
Vermögen: 6 Mio $ am 30.04.2024
Profil
Derzeit bekleidet Rene D. Gal die Position des Chief Financial Officer & Executive Vice President von Jazz Pharmaceuticals Plc. Sie ist außerdem im Vorstand von Gossamer Bio, Inc. und Gyroscope Therapeutics Ltd. In der Vergangenheit hatte sie die Position des Chief Financial Officer, Treasurer & Senior VP bei Theravance Biopharma, Inc. inne, war Chief Financial Officer bei GRAIL, Inc. und Vice President-Finance bei Innoviva, Inc. sowie Principal bei Eli Lilly & Company (Ireland) Ltd. Rene D. Gal erhielt einen Undergraduate-Abschluss von der Vanderbilt University und einen MBA von der Columbia Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.04.2024 | 55 357 ( 0,09% ) | 6 Mio $ | 30.04.2024 | |
GOSSAMER BIO, INC.
-.--% | 16.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Renée Galá
| Unternehmen | Position | Beginn |
|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Präsident | 01.10.2023 |
Jazz Pharmaceuticals Ireland Ltd.
 Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. | Präsident | 01.01.2020 |
Ehemalige bekannte Positionen von Renée Galá
| Unternehmen | Position | Ende |
|---|---|---|
| GOSSAMER BIO, INC. | Direktor/Vorstandsmitglied | Heute |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Finanzdirektor/CFO | 01.03.2024 |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Direktor/Vorstandsmitglied | 17.02.2022 |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Direktor/Vorstandsmitglied | 01.02.2022 |
GRAIL LLC
 GRAIL LLC Medical SpecialtiesHealth Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Finanzdirektor/CFO | 06.06.2019 |
Ausbildung von Renée Galá
| Vanderbilt University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| INNOVIVA, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| GOSSAMER BIO, INC. | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| Private Unternehmen | 6 |
|---|---|
GRAIL LLC
GRAIL LLC Medical SpecialtiesHealth Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Health Technology |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Eli Lilly & Company (Ireland) Ltd.
 Eli Lilly & Company (Ireland) Ltd. Medical DistributorsDistribution Services Part of Eli Lilly & Co., Eli Lilly & Company (Ireland) Ltd. is an Irish pharmaceutical company that focuses on creating medicines to improve people's lives globally. The company is based in Dublin, Ireland. The company partners with government and regulatory agencies to ensure the safety of patients who use their medicines. Eli Lilly & Company has been a leader in the fight against Alzheimer's disease for over 30 years and conducts clinical development and research ethics to improve their products. | Distribution Services |
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Jazz Pharmaceuticals Ireland Ltd.
Jazz Pharmaceuticals Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Jazz Pharmaceuticals Plc, Jazz Pharmaceuticals Ireland Ltd. is an Irish biopharmaceutical company that focuses on the identification, development, and commercialization of pharmaceutical products. The company is based in Dublin, Ireland. The company was founded by Bruce C. Cozadd, who has been the CEO since incorporation. | Health Technology |